Attached files
file | filename |
---|---|
10-Q/A - 10-Q/A - ANGIOTECH PHARMACEUTICALS INC | a12-26526_110qa.htm |
EX-2.1 - EX-2.1 - ANGIOTECH PHARMACEUTICALS INC | a12-26526_1ex2d1.htm |
EX-31.2 - EX-31.2 - ANGIOTECH PHARMACEUTICALS INC | a12-26526_1ex31d2.htm |
EX-10.1 - EX-10.1 - ANGIOTECH PHARMACEUTICALS INC | a12-26526_1ex10d1.htm |
EX-32.1 - EX-32.1 - ANGIOTECH PHARMACEUTICALS INC | a12-26526_1ex32d1.htm |
EX-31.1 - EX-31.1 - ANGIOTECH PHARMACEUTICALS INC | a12-26526_1ex31d1.htm |
EXHIBIT 32.2
Certification of Principal Financial Officer Pursuant to
18 U.S.C. Section 1350,
as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
The undersigned, the Principal Financial Officer of Angiotech Pharmaceuticals, Inc. (the Company), hereby certifies that to his knowledge on the date hereof:
(a) The Amendment No. 2 to the Companys Quarterly Report on Form 10-Q for the quarter ended June 30, 2012, filed on the date hereof with the Securities and Exchange Commission (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(b) Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
Date: November 13, 2012 |
/s/ Jay Dent |
|
Jay Dent |